Literature DB >> 222519

Induction of plaque-forming cells in human blood lymphocytes cultured in the presence of antigen and Epstein-Barr virus: a study with normal donors and infectious mononucleosis patients.

A L Luzzati, I Heinzer, H Hengartner, M H Schreier.   

Abstract

Normal human peripheral blood lymphocytes, stimulated in vitro with SRBC in the presence of Epstein-Barr virus (EBV), gave rise to plaque-forming cells (PFC) specific for the antigen. PFC levels were very low before day 4 and increased thereafter, reaching a maximum around day 8. However, the kinetics of the response varied considerably from donor to donor and from experiment to experiment. In some instances a second peak of PFC was obtained beyond day 10. Large differences in the magnitude of the response were observed among different normal donors, the overall responsiveness range covering four orders of magnitude. Peripheral blood lymphocytes from infectious mononucleosis patients in the acute stage of the disease, when a high titre of heterophil and anti-EBV antibodies were present, did not give rise to PFC. A return to normal responses was observed during recovery from the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222519      PMCID: PMC1537610     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.

Authors:  A Rosén; P Gergely; M Jondal; G Klein; S Britton
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

Review 2.  Recent progress in Epstein-Barr virus research.

Authors:  M A Epstein; B G Achong
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

3.  Induction of plaque-forming cells in cultured human lymphocytes by combined action of antigen and EB virus.

Authors:  A L Luzzati; H Hengartner; M H Schreier
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Genetic control of primary and secondary IgG responses to sheep erythrocytes in mice.

Authors:  I Ando; J Fachet
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Tuberculin anergy and infectious mononucleosis.

Authors:  S Haider; M de L Coutinho; R T Emond; R N Sutton
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

7.  Pathogenesis of infectious mononucleosis.

Authors:  M A Epstein; B G Achong
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

8.  Suppressor cells in rabbit peripheral blood.

Authors:  A L Luzzati; L Lafleur
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

9.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  2 in total

1.  Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.

Authors:  P Segond; D Salliere; P Galanaud; R M Desmottes; P Massias; J N Fiessinger
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

2.  Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.